44/60
3.7 / 5 stars
All 60 Win/Lose results and 60 gray no-data contests shown below
SIBN Roast Me summary
SI-BONE, Inc. (SIBN). Every strict quarterly win earns 1 point. A loss or tie earns 0. A contest with no data is a gray cell, neither a win nor a loss, and leaves the total: stars are 5 × points won ÷ contests with data.
- 2026-Q2: Total return Win; Revenue growth Win; EPS growth No data.
- 2026-Q1: Total return Lose; Revenue growth Win; EPS growth No data.
- 2025-Q4: Total return Win; Revenue growth Win; EPS growth No data.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth No data.
Trailing 1 year (4 quarters): 6 wins, 2 losses, 4 no dataLast fetched: 25 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q22/2 |
WinSIBN / S&P 29.22% / 15.20% |
WinSIBN / S&P 15.30% / 15.00% |
No dataSIBN / S&P / 50.40% |
| 2026-Q11/2 |
LoseSIBN / S&P -35.95% / -4.33% |
WinSIBN / S&P 16.77% / 11.30% |
No dataSIBN / S&P / 27.70% |
| 2025-Q42/2 |
WinSIBN / S&P 33.97% / 2.65% |
WinSIBN / S&P 20.19% / 9.00% |
No dataSIBN / S&P / 13.40% |
| 2025-Q31/2 |
LoseSIBN / S&P -21.79% / 8.12% |
WinSIBN / S&P 23.27% / 4.61% |
No dataSIBN / S&P / 13.45% |
| 2025-Q22/2 |
WinSIBN / S&P 34.14% / 10.94% |
WinSIBN / S&P 22.93% / 4.83% |
No dataSIBN / S&P / 10.63% |
| 2025-Q12/2 |
WinSIBN / S&P 0.07% / -4.27% |
WinSIBN / S&P 22.60% / 4.98% |
No dataSIBN / S&P / 10.57% |
| 2024-Q41/2 |
LoseSIBN / S&P 0.29% / 2.41% |
WinSIBN / S&P 20.37% / 5.25% |
No dataSIBN / S&P / 6.15% |
| 2024-Q32/2 |
WinSIBN / S&P 8.12% / 5.89% |
WinSIBN / S&P 18.98% / 5.89% |
No dataSIBN / S&P / 6.11% |
| 2024-Q21/2 |
LoseSIBN / S&P -21.01% / 4.28% |
WinSIBN / S&P 21.15% / 5.38% |
No dataSIBN / S&P / 5.12% |
| 2024-Q11/2 |
LoseSIBN / S&P -22.01% / 10.56% |
WinSIBN / S&P 23.46% / 5.71% |
No dataSIBN / S&P / 5.59% |
| 2023-Q41/2 |
LoseSIBN / S&P -1.18% / 11.69% |
WinSIBN / S&P 30.52% / 6.81% |
No dataSIBN / S&P / 7.78% |
| 2023-Q31/2 |
LoseSIBN / S&P -21.28% / -3.27% |
WinSIBN / S&P 32.40% / 7.52% |
No dataSIBN / S&P / -5.03% |
| 2023-Q22/2 |
WinSIBN / S&P 37.16% / 8.74% |
WinSIBN / S&P 30.21% / 9.50% |
No dataSIBN / S&P / -8.57% |
| 2023-Q12/2 |
WinSIBN / S&P 44.63% / 7.50% |
WinSIBN / S&P 26.62% / 10.77% |
No dataSIBN / S&P / -15.69% |
| 2022-Q41/2 |
LoseSIBN / S&P -22.11% / 7.56% |
WinSIBN / S&P 18.03% / 11.88% |
No dataSIBN / S&P / -17.99% |
| 2022-Q32/2 |
WinSIBN / S&P 32.27% / -4.88% |
WinSIBN / S&P 14.49% / 13.47% |
No dataSIBN / S&P / -1.41% |
| 2022-Q20/2 |
LoseSIBN / S&P -41.59% / -16.10% |
LoseSIBN / S&P 12.20% / 13.71% |
No dataSIBN / S&P / 11.04% |
| 2022-Q12/2 |
WinSIBN / S&P 1.76% / -4.60% |
WinSIBN / S&P 19.66% / 15.97% |
No dataSIBN / S&P / 42.23% |
| 2021-Q41/2 |
LoseSIBN / S&P 3.69% / 11.03% |
WinSIBN / S&P 22.84% / 15.00% |
No dataSIBN / S&P / 96.40% |
| 2021-Q31/2 |
LoseSIBN / S&P -31.94% / 0.58% |
WinSIBN / S&P 22.53% / 10.77% |
No dataSIBN / S&P / 69.42% |
| 2021-Q21/2 |
LoseSIBN / S&P -1.07% / 8.55% |
WinSIBN / S&P 27.35% / 6.58% |
No dataSIBN / S&P / 51.81% |
| 2021-Q12/2 |
WinSIBN / S&P 6.39% / 6.17% |
WinSIBN / S&P 11.39% / -1.06% |
No dataSIBN / S&P / 7.39% |
| 2020-Q42/2 |
WinSIBN / S&P 26.05% / 12.15% |
WinSIBN / S&P 9.04% / -3.72% |
No dataSIBN / S&P / -33.42% |
| 2020-Q32/2 |
WinSIBN / S&P 48.81% / 8.93% |
WinSIBN / S&P 12.58% / -2.04% |
No dataSIBN / S&P / -27.10% |
| 2020-Q22/2 |
WinSIBN / S&P 33.39% / 20.54% |
WinSIBN / S&P 10.86% / -0.46% |
No dataSIBN / S&P / -27.11% |
| 2020-Q11/2 |
LoseSIBN / S&P -44.42% / -19.60% |
WinSIBN / S&P 19.90% / 3.47% |
No dataSIBN / S&P / -14.75% |
| 2019-Q42/2 |
WinSIBN / S&P 21.68% / 9.07% |
WinSIBN / S&P 21.53% / 5.36% |
No dataSIBN / S&P / 2.99% |
| 2019-Q31/2 |
LoseSIBN / S&P -13.13% / 1.70% |
WinSIBN / S&P 17.91% / 5.02% |
No dataSIBN / S&P / 0.21% |
| 2019-Q22/2 |
WinSIBN / S&P 7.96% / 4.30% |
WinSIBN / S&P 16.37% / 6.64% |
No dataSIBN / S&P / 8.65% |
| 2019-Q10/1 |
LoseSIBN / S&P -9.81% / 13.65% |
No dataSIBN / S&P / 8.12% |
No dataSIBN / S&P / 14.29% |
| 2018-Q41/1 |
No dataSIBN / S&P / -13.52% |
WinSIBN / S&P 15.42% / 9.05% |
No dataSIBN / S&P / 18.23% |
| 2018-Q30/0 |
No dataSIBN / S&P / 7.71% |
No dataSIBN / S&P / 10.21% |
No dataSIBN / S&P / 19.06% |
| 2018-Q20/0 |
No dataSIBN / S&P / 3.43% |
No dataSIBN / S&P / 9.03% |
No dataSIBN / S&P / 14.46% |
| 2018-Q10/0 |
No dataSIBN / S&P / -0.76% |
No dataSIBN / S&P / 7.68% |
No dataSIBN / S&P / 12.46% |
| 2017-Q40/0 |
No dataSIBN / S&P / 6.64% |
No dataSIBN / S&P / 7.03% |
No dataSIBN / S&P / 13.82% |
| 2017-Q30/0 |
No dataSIBN / S&P / 4.48% |
No dataSIBN / S&P / 5.68% |
No dataSIBN / S&P / 17.57% |
| 2017-Q20/0 |
No dataSIBN / S&P / 3.09% |
No dataSIBN / S&P / 4.83% |
No dataSIBN / S&P / 17.74% |
| 2017-Q10/0 |
No dataSIBN / S&P / 6.07% |
No dataSIBN / S&P / 3.67% |
No dataSIBN / S&P / 13.32% |
| 2016-Q40/0 |
No dataSIBN / S&P / 3.82% |
No dataSIBN / S&P / 2.09% |
No dataSIBN / S&P / 7.05% |
| 2016-Q30/0 |
No dataSIBN / S&P / 3.85% |
No dataSIBN / S&P / 0.20% |
No dataSIBN / S&P / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | SIBN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 15.42% | 20.78% |
| Annualized return | 15.42% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | SIBN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -22.36% | 83.14% |
| Annualized return | -4.93% | 12.86% |
10Y · 2018-10-17 to 2026-08-28
| Metric | SIBN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -4.09% | 319.30% |
| Annualized return | -0.42% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-25.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |